Pharmacovigilance teaching in UK undergraduate pharmacy programmes

Pharmacoepidemiology and Drug Safety

Volumn 22, Issue 3, 2013, Pages 223-228

  Smith, Melvyn P ^a   Webley, Sherael D ^a  

^a UNIVERSITY OF HERTFORDSHIRE   (United Kingdom)

Author keywords

Adverse drug reactions; Education; Pharmacoepidemiology; Pharmacovigilance; Pharmacy degree

Indexed keywords

ARTICLE; CROSS-SECTIONAL STUDY; DRUG SURVEILLANCE PROGRAM; EDUCATION PROGRAM; HUMAN; MEDICAL EDUCATION; PHARMACIST; PHARMACY; PHARMACY STUDENT; PRIORITY JOURNAL; SCHOOL; UNDERGRADUATE STUDENT; UNITED KINGDOM;

ADVERSE DRUG REACTION REPORTING SYSTEMS; CROSS-SECTIONAL STUDIES; CURRICULUM; DATA COLLECTION; DRUG AND NARCOTIC CONTROL; EDUCATION, PHARMACY; GREAT BRITAIN; HUMANS; PHARMACOEPIDEMIOLOGY; PHARMACOVIGILANCE; PROFESSIONAL ROLE; QUESTIONNAIRES; TEACHING; TIME FACTORS;

EID: 84874548978     PISSN: 10538569     EISSN: 10991557     Source Type: Journal    
DOI: 10.1002/pds.3311     Document Type: Article

References (38)

1. Pirmohamed M, Breckenridge AM, Kitteringham NR, et al. Adverse drug reactions. Br Med J 1998; 316: pp. 1295-1298.
2. Einarson TR. Drug-related hospital admissions. Ann Pharmacother 1993; 27: 832-840.
3. Pirmohamed M, James S, Meakin S, et al. Adverse drug reactions as cause of admission to hospital: prospective analysis of 18 820 patients. Br Med J 2004; 329: 15-19.
4. Sundström, Anders and Hallberg, Pär. 32. 2009. Data Mining in Pharmacovigilance - Detecting the Unexpected. The Role of Index of Suspicion of the Reported. Drug Saf 5: pp. 419-427.
5. United Kingdom Department of Health. Report of an independent review of access to the Yellow Card Scheme. The Stationary Office (Chairman J. Metters): London, 2004.
6. Metters Jeremy. Report of an Independent Review of Access to the Yellow Card Scheme. Te Stationary Office: London, 2004.
7. Morrison-Griffiths S, et al. Reporting of adverse drug reaction by nurses. Lancet 2003; 361: 9366.
8. RCGP. Patient reporting of adverse drug reactions. January 17-23, 2005, Seven Days.
9. Centre, NHS Information. Prescriptions dispensed in the Community 1997-2007. UK National Statistics: London. http://www.ic.nhs.uk/pubs/presdisp97-07 (last accessed 7.10.2011).
10. Hazell Lorna, Shakir AW. Under-Reporting of Adverse Drug Reactions A systematic Review. Drug Saf 2006; 5: pp. 385-396.
11. Nicholas V, Theriault-Dube I, Touzin J, et al. Risk perception and reasons for noncompliance in pharmacovigilance - a qualitative study conducted in Canada. Drug Saf 2009; 32: 579-590.
12. Changhai Su, Hui Ji, Yixin Su. Hospital pharmacists' knowledge and opinions regarding adverse drug reaction reporting in Northern China. Pharmacoepidemology and Drug Safety 2010; 19: pp. 217-222.
13. Oreagba A, Ogunleye OJ, Olayemi SO. The knowledge, perception and practice of pharmacovigilance amongst community pharmacists in Lagos state, south west Nigeria. Pharmacoepidemiol Drug Saf 2010; 20(10): pp. 30-35.
14. Garcia M, Figueras A. The lack of knowledge about the voluntary reporting system of adverse drug reactions as a major cause of underreporting: direct survey among health professionals. Pharmacoepidemiol Drug Saf 2011; 20(12): 1295-1302.
15. Gavaza P, Brown C, Lawson K, Rascati K, Wilson J, Steinhardt M. Influence of attitudes on pharmacists' intention to report serious adverse drug events to the Food and Drug Administration. Br J Clin Pharmacol 2011; 11: 1365-2125.
16. Lopez-Gonzalez E. Herdeiro MT, Figueiras A. Determinants of Under-Reporting of Adverse Drug Reactions. Drug Saf 2009; 32: pp. 19-31.
17. Sears EL, Generali JA. Adverse Drug Reaction and Medication Error reporting by Pharmacy Students. Ann Pharmacother 2005; 39: pp. 452-459.
18. Sweis D, Wong ICK. A survey of Factors that Could Affect Adverse Drug Reaction Reporting According to Hospital Pharmacists in Great Britain. Drug Saf 2000; 2: 165-172.
19. Herdeiro MT, et al. Influence of Pharmacists' Attitudes on Adverse Drug Reaction Reporting. Drug Saf 2006; 4(29): pp. 331-340.
20. Irujo M, Beitia G, Bes-Rastrollo M. Factors that influence under-reporting of suspected adverse drug reactions amongst community pharmacists in a Spanish region. Drug Saf 2007; 30: 1073-1082.
21. Christensen ST, Sondergaard B, Honore PH, et al. Pharmacy student driven detection of adverse drug reactions in the community pharmacy setting. Pharmacoepidemiol Drug Saf 2011; 20: 399-404.
22. Royal Pharmaceutical Society. MPharm outcomes and indicative syllabus. Royal Pharmaceutical Society: London, 2008.
23. Smith A, Darracott R. Modernising Pharmacy Careers Programme: Review of pharmacist undergraduate education and pre-registration training and proposals for reform. Medical Education England: London, 2011; 404593.
24. Youssef S, Aspinall V, Upton D. Medicines use review workshops for pharmacy undergraduate students. Pharmaceutical Journal 2009; 283: pp. 221-222.
25. Sullivan KM, Spooner LM. Adverse-drug-reaction reporting by pharmacy students in a teaching hospital. Am J Health Syst Pharm 2008; 65: pp. 1177-9.
26. Cox AR, et al. Adverse drug reaction teaching in UK undergraduate medical and pharmacy programmes. J Clin Pharm Ther 2004; 29: pp. 31-35.
27. van Grootheest K, Olsson S, Couper M. Pharmacists' role in reporting adverse drug reactions in an international perspective. Pharmacoepidemiol Drug Saf 2004; 13: 457-464.
28. Granas AG, et al. Pharmacists' attitudes towards the reporting of suspected adverse drug reactions in Norway. Pharmacoepidemiol Drug Saf 2007; 16: pp. 429-434.
29. Drug Safety Research. Unit training courses. [Online] [Cited June 2012.] www.dsru.org.
30. WHO. WHO Pharmacovigilance training courses. [Online] [Cited: January 26, 2012.] http://www.who.int/medicines/areas/quality_safety/safety_efficacy/trainingcourses/en/index.html.
31. Randall C. Adverse drug reactions. 4th. Manchester: Centre for Pharmacy Postgraduate Education. 2009.
32. University of Hertfordshire. [Online] [Cited: January 26th, 2012.] www.herts.ac.uk.
33. DIRECTIVE 2010/84/EU OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL. Official Journal of the European Union. 2010.
34. REGULATION (EU) No 1235/2010 OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL. Official Journal of the European Union. 2010.
35. Herdeiro MT, et al. Improving the reporting of adverse drug reactions: a cluster-randomized trial among pharmacists in Portugal. Drug Saf 2008; 31(4): pp. 335-344.
36. Nelson E. The Contribution of Pharmacy to making Britain a Safer Place to Take Medicines. Policy Development Unit, The Royal Pharmaceutical Society of Great Britain. 2009.
37. Cox A, Davis E. Pharmacovigilance is for everyone. Pharm J 2009; 283: p. 14.
38. MHRA. www.mhra.gov.uk/Safetyinformation/Reportingsafetyproblems/Reportinguspectedadversedrugreactions/Patientreporting/index.htm. Last accessed 30 May 2011.